Cargando…

Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma

The dysregulation of Fbxo4-cyclin D1 axis occurs at high frequency in esophageal squamous cell carcinoma (ESCC), where it promotes ESCC development and progression. However, defining a therapeutic vulnerability that results from this dysregulation has remained elusive. Here we demonstrate that Rb an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qie, Shuo, Yoshida, Akihiro, Parnham, Stuart, Oleinik, Natalia, Beeson, Gyda C., Beeson, Craig C., Ogretmen, Besim, Bass, Adam J., Wong, Kwok-Kin, Rustgi, Anil K., Diehl, J. Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428878/ https://www.ncbi.nlm.nih.gov/pubmed/30899002 http://dx.doi.org/10.1038/s41467-019-09179-w

Ejemplares similares

Ceramide Synthase 6 Maximizes p53 Function to Prevent Progeny Formation from Polyploid Giant Cancer Cells
por: Lu, Ping, et al.
Publicado: (2021)

Mitochondrial C3a Receptor Activation in Oxidatively Stressed Epithelial Cells Reduces Mitochondrial Respiration and Metabolism
por: Ishii, Masaaki, et al.
Publicado: (2021)

Mitochondria-Targeted Catalase Reverts the Neurotoxicity of hSOD1(G93A) Astrocytes without Extending the Survival of ALS-Linked Mutant hSOD1 Mice
por: Pehar, Mariana, et al.
Publicado: (2014)

CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma
por: Zhou, Jin, et al.
Publicado: (2017)

Pan-ERBB kinase inhibition augments CDK4/6 inhibitor efficacy in oesophageal squamous cell carcinoma
por: Zhou, Jin, et al.
Publicado: (2022)

Aging-dependent mitochondrial dysfunction mediated by ceramide signaling inhibits antitumor T cell response
por: Vaena, Silvia, et al.
Publicado: (2021)

Targeting Glutamine Addiction in Gliomas
por: Obara-Michlewska, Marta, et al.
Publicado: (2020)

Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
por: Ni, Rui, et al.
Publicado: (2023)

CDK4/6 inhibitor: from quiescence to senescence
por: Yoshida, Akihiro, et al.
Publicado: (2015)

SLC36A1-mTORC1 signaling drives acquired resistance to CDK4/6 inhibitors
por: Yoshida, Akihiro, et al.
Publicado: (2019)

Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor Activity
por: Chakraborty, Paramita, et al.
Publicado: (2019)

Regulation of PP2A by Sphingolipid Metabolism and Signaling
por: Oaks, Joshua, et al.
Publicado: (2015)

The Role of Ceramide Metabolism and Signaling in the Regulation of Mitophagy and Cancer Therapy
por: Sheridan, Megan, et al.
Publicado: (2021)

Mitochondrial protein import is regulated by p17/PERMIT to mediate lipid metabolism and cellular stress
por: Oleinik, Natalia, et al.
Publicado: (2019)

Repurposing Kir6/SUR2 Channel Activator Minoxidil to Arrests Growth of Gynecologic Cancers
por: Fukushiro-Lopes, Daniela, et al.
Publicado: (2020)

Targeting Sphingolipid Metabolism as a Therapeutic Strategy in Cancer Treatment
por: Janneh, Alhaji H., et al.
Publicado: (2022)

Glutamine Addiction and Therapeutic Strategies in Lung Cancer
por: Vanhove, Karolien, et al.
Publicado: (2019)

Distinct effects of etoposide on glutamine-addicted neuroblastoma
por: Valter, Kadri, et al.
Publicado: (2019)

TAp73 is a marker of glutamine addiction in medulloblastoma
por: Niklison-Chirou, Maria Victoria, et al.
Publicado: (2017)

Dietary Folic Acid Alters Metabolism of Multiple Vitamins in a CerS6- and Sex-Dependent Manner
por: Barron, Keri, et al.
Publicado: (2021)

A new fluorescent sensor mitoferrofluor indicates the presence of chelatable iron in polarized and depolarized mitochondria
por: Kholmukhamedov, Andaleb, et al.
Publicado: (2022)

A Screen Using iPSC-Derived Hepatocytes Reveals NAD(+) as a Potential Treatment for mtDNA Depletion Syndrome
por: Jing, Ran, et al.
Publicado: (2018)

Glutamate and asparagine cataplerosis underlie glutamine addiction in melanoma
por: Ratnikov, Boris, et al.
Publicado: (2015)

Hopefully devoted to Q: targeting glutamine addiction in cancer
por: Still, Emma R, et al.
Publicado: (2017)

Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1‐driven acute lymphoblastic leukemia
por: Nguyen, Tra Ly, et al.
Publicado: (2021)

Flavin Adenine Dinucleotide Depletion Caused by electron transfer flavoprotein subunit alpha Haploinsufficiency Leads to Hepatic Steatosis and Injury in Zebrafish
por: Park, Ki‐Hoon, et al.
Publicado: (2021)

Addiction to Coupling of the Warburg Effect with Glutamine Catabolism in Cancer Cells
por: Smith, Bradley, et al.
Publicado: (2016)

Correction: Hopefully devoted to Q: targeting glutamine addiction in cancer
por: Still, Emma R., et al.
Publicado: (2019)

A CINful way to overcome addiction: how chromosomal instability enables cancer to overcome its oncogene addiction
por: Bronder, Daniel, et al.
Publicado: (2020)

Glutamine is essential for overcoming the immunosuppressive microenvironment in malignant salivary gland tumors
por: Cao, Shuting, et al.
Publicado: (2022)

Regulation of glucose and glutamine metabolism to overcome cisplatin resistance in intrahepatic cholangiocarcinoma
por: Yang, So Mi, et al.
Publicado: (2023)

Alterations of lipid‐mediated mitophagy result in aging‐dependent sensorimotor defects
por: Oleinik, Natalia, et al.
Publicado: (2023)

Glutamine addiction promotes glucose oxidation in triple-negative breast cancer
por: Quek, Lake-Ee, et al.
Publicado: (2022)

HPV/E7 induces chemotherapy‐mediated tumor suppression by ceramide‐dependent mitophagy
por: Thomas, Raquela J, et al.
Publicado: (2017)

Sphingolipid metabolism in T cell responses after allogeneic hematopoietic cell transplantation
por: Tian, Linlu, et al.
Publicado: (2022)

Fbxl8 suppresses lymphoma growth and hematopoietic transformation through degradation of cyclin D3
por: Yoshida, Akihiro, et al.
Publicado: (2020)

Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer
por: Al-Qasem, Abeer J., et al.
Publicado: (2022)

Predicting and overcoming resistance to CDK9 inhibitors for cancer therapy
por: Hu, Chen, et al.
Publicado: (2023)

Tumor suppressor mediated ubiquitylation of hnRNPK is a barrier to oncogenic translation
por: Mucha, Bartosz, et al.
Publicado: (2022)

Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction
por: Fogal, Valentina, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qijtrq6qshcfemlln2jutdmgcb